Autor: |
Gouvas Nikolaos, Kalambaliki Telenia, Voutsina Alexandra, Saridaki Zenia, Tzardi Maria, Kalykaki Aristea, Sfakianaki Maria, Athanasiadis Athanasios, Xynos Evaghelos, Boukovinas Ioannis, Souglakos John |
Jazyk: |
angličtina |
Rok vydání: |
2019 |
Předmět: |
|
Zdroj: |
Forum of Clinical Oncology, Vol 9, Iss 1, Pp 31-36 (2019) |
Druh dokumentu: |
article |
ISSN: |
1792-362X |
DOI: |
10.2478/fco-2018-0005 |
Popis: |
Several studies show that mutational profiles could influence treatment decisions in patients with metastatic CRC (mCRC). KRAS mutational status was the first step in biomarkers development in the era of molecular targeted therapies. Recently, NRAS mutational status was identified as an independent prognostic factor for the response to treatment with anti-EGFR moAbs. The aim of this observational study was to assess the feasibility of the KRAS/NRAS mutational analysis in patients with metastatic colorectal cancer in Greece and to identify any correlations with known clinical characteristics and histopathologic features. |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|